Credit Suisse Ag Adma Biologics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 316,693 shares of ADMA stock, worth $5.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

316,693

Previous 339,650 6.76%

Holding current value

$5.84 Million

Previous $1.54 Million 36.16%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$4.4 - $6.74 $101,010 - $154,730	-22,957 Reduced 6.76%	316,693 $2.09 Million
Q4 2023 Feb 08, 2024	SELL	$3.08 - $4.52 $1,567 - $2,300	-509 Reduced 0.15%	339,650 $1.54 Million
Q3 2023 Nov 13, 2023	SELL	$3.47 - $4.61 $204,830 - $272,123	-59,029 Reduced 14.79%	340,159 $1.22 Million
Q2 2023 Aug 11, 2023	BUY	$3.12 - $4.22 $517,218 - $699,570	165,775 Added 71.02%	399,188 $1.47 Million
Q1 2023 May 10, 2023	BUY	$3.01 - $3.87 $31,144 - $40,042	10,347 Added 4.64%	233,413 $772,000
Q4 2022 Feb 13, 2023	BUY	$2.47 - $3.88 $548,342 - $861,363	222,001 Added 20845.16%	223,066 $865,000
Q3 2022 Nov 10, 2022	BUY	$2.03 - $2.86 $1,977 - $2,785	974 Added 1070.33%	1,065 $3,000
Q2 2022 Aug 12, 2022	BUY	$1.43 - $2.2 $130 - $200	91 New	91 $0
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.66 $38,150 - $58,100	-35,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.13 - $1.65 $39,549 - $57,750	35,000 New	35,000 $40,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.07 $27,675 - $37,938	-18,328 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.67 - $2.95 $6,168 - $10,897	3,694 Added 25.24%	18,328 $32,000
Q4 2020 Feb 12, 2021	BUY	$1.8 - $2.56 $26,341 - $37,463	14,634 New	14,634 $28,000
Q4 2019 Feb 12, 2020	SELL	$3.89 - $5.15 $47,310 - $62,634	-12,162 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$3.19 - $5.39 $38,796 - $65,553	12,162 New	12,162 $54,000

Others Institutions Holding ADMA

# of Institutions

318

Shares Held

184M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.62B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account